The Heinz Nixdorf Recall Study and Its Potential Impact on the Adoption of Atherosclerosis Imaging in European Primary Prevention Guidelines

  • Amir A. Mahabadi
  • Stefan Möhlenkamp
  • Susanne Moebus
  • Nico Dragano
  • Hagen Kälsch
  • Marcus Bauer
  • Karl-Heinz Jöckel
  • Raimund Erbel
  • on behalf of the Heinz Nixdorf Investigator Group
Article

Abstract

Non–contrast-enhanced computed tomography (CT) imaging of the heart enables noninvasive quantification of coronary artery calcification (CAC), a surrogate marker of the atherosclerotic burden in the coronary artery tree. Multiple studies have underlined the ability of CAC score for individual risk stratification and, accordingly, the American Heart Association recommended cardiac CT for risk assessment in individuals with an intermediate risk of cardiovascular events as measured by Framingham Risk Score. However, limitations in transcribing risk stratification algorithms based on American cohort studies into European populations have been acknowledged in the past. Moreover, data on implications for reclassification into higher- or lower-risk groups based on CAC scores were lacking. The Heinz Nixdorf Recall (HNR) study is a population-based cohort study that investigated the ability of CAC scoring in risk prediction for major cardiovascular events above and beyond traditional cardiovascular risk factors. According to Heinz Nixdorf Recall findings, CAC can be used for reclassification, especially in those in the intermediate-risk group, to advise on lifestyle changes for the reclassified low-risk category, or to implement intensive treatments for the reclassified high-risk individuals. This article discusses the present findings of the Heinz Nixdorf Recall Study with respect to the current literature, risk stratification algorithms, and current European guidelines for risk prediction.

Keywords

Coronary artery calcification Heinz Nixdorf Recall Study Risk prediction Primary prevention European guidelines Electron beam computed tomography 

Notes

Disclosure

No conflicts of interest relevant to this article were reported.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 2000;101:850–5.PubMedGoogle Scholar
  2. 2.
    Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210–5.PubMedCrossRefGoogle Scholar
  3. 3.
    •• Erbel R, Mohlenkamp S, Moebus S, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol. 2010;56:1397–406. This article shows the clinical value of CAC quantification in a European population-based cohort study.PubMedCrossRefGoogle Scholar
  4. 4.
    Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–45.PubMedCrossRefGoogle Scholar
  5. 5.
    Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation. 2007;115:402–26.PubMedCrossRefGoogle Scholar
  6. 6.
    Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14 Suppl 2:E1–40.PubMedCrossRefGoogle Scholar
  7. 7.
    Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation. 2011;123:e18–e209.PubMedCrossRefGoogle Scholar
  8. 8.
    Dudas K, Lappas G, Stewart S, Rosengren A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006). Circulation 123:46–52.Google Scholar
  9. 9.
    Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657–71.PubMedGoogle Scholar
  10. 10.
    Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes 3rd J. Factors of risk in the development of coronary heart disease–six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33–50.PubMedGoogle Scholar
  11. 11.
    Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med. 2007;357:1477–86.PubMedCrossRefGoogle Scholar
  12. 12.
    Shah T, Swerdlow D. Detecting, predicting and modifying cardiovascular risk: new and developing strategies. Expert Rev Cardiovasc Ther. 2010;8:1519–21.PubMedCrossRefGoogle Scholar
  13. 13.
    Brindle P, Emberson J, Lampe F, et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ. 2003;327:1267.PubMedCrossRefGoogle Scholar
  14. 14.
    Mohlenkamp S, Bose D, Mahabadi AA, Heusch G, Erbel R. On the paradox of exercise: coronary atherosclerosis in an apparently healthy marathon runner. Nat Clin Pract Cardiovasc Med. 2007;4:396–401.PubMedCrossRefGoogle Scholar
  15. 15.
    Akosah KO, Schaper A, Cogbill C, Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol. 2003;41:1475–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation. 1995;92:2157–62.PubMedGoogle Scholar
  17. 17.
    Baumgart D, Schmermund A, Goerge G, et al. Comparison of electron beam computed tomography with intracoronary ultrasound and coronary angiography for detection of coronary atherosclerosis. J Am Coll Cardiol. 1997;30:57–64.PubMedCrossRefGoogle Scholar
  18. 18.
    Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte Jr M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–32.PubMedCrossRefGoogle Scholar
  19. 19.
    Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final Report. NIH Publication No. 02–5215. 2002 Sep.Google Scholar
  20. 20.
    Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation. 2003;107:2571–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228:826–33.PubMedCrossRefGoogle Scholar
  22. 22.
    Vliegenthart R, Oudkerk M, Hofman A, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation. 2005;112:572–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol. 2005;46:158–65.PubMedCrossRefGoogle Scholar
  24. 24.
    Blaha M, Budoff MJ, Shaw LJ, et al. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging. 2009;2:692–700.PubMedCrossRefGoogle Scholar
  25. 25.
    Tsang TS, Abhayaratna WP, Barnes ME, et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol. 2006;47:1018–23.PubMedCrossRefGoogle Scholar
  26. 26.
    Mahabadi AA, Truong QA, Schlett CL, et al. Axial area and anteroposterior diameter as estimates of left atrial size using computed tomography of the chest: comparison with 3-dimensional volume. J Cardiovasc Comput Tomogr 4:49–54Google Scholar
  27. 27.
    Mahabadi AA, Massaro JM, Rosito GA, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J. 2009;30:850–6.PubMedCrossRefGoogle Scholar
  28. 28.
    De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10:S1–S10.PubMedCrossRefGoogle Scholar
  29. 29.
    Schmermund A, Mohlenkamp S, Stang A, et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J. 2002;144:212–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Schmermund A, Lehmann N, Bielak LF, et al. Comparison of subclinical coronary atherosclerosis and risk factors in unselected populations in Germany and US-America. Atherosclerosis. 2007;195:e207–216.PubMedCrossRefGoogle Scholar
  31. 31.
    Erbel R, Mohlenkamp S, Lehmann N, et al. Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. Atherosclerosis. 2008;197:662–72.PubMedCrossRefGoogle Scholar
  32. 32.
    • Jockel KH, Lehmann N, Jaeger BR, et al. Smoking cessation and subclinical atherosclerosis–results from the Heinz Nixdorf Recall Study. Atherosclerosis. 2009;203:221–7. This article shows the association of smoking cessation and presence of subclinical atherosclerosis as a result from the Heinz Nixdorf Recall Study.PubMedCrossRefGoogle Scholar
  33. 33.
    Hoffmann B, Moebus S, Mohlenkamp S, et al. Residential exposure to traffic is associated with coronary atherosclerosis. Circulation. 2007;116:489–96.PubMedCrossRefGoogle Scholar
  34. 34.
    Dragano N, Verde PE, Moebus S, et al. Subclinical coronary atherosclerosis is more pronounced in men and women with lower socio-economic status: associations in a population-based study. Coronary atherosclerosis and social status. Eur J Cardiovasc Prev Rehabil. 2007;14:568–74.PubMedCrossRefGoogle Scholar
  35. 35.
    Stang A, Dragano N, Poole C, et al. Daily siesta, cardiovascular risk factors, and measures of subclinical atherosclerosis: results of the Heinz Nixdorf Recall Study. Sleep. 2007;30:1111–9.PubMedGoogle Scholar
  36. 36.
    Erbel R, Delaney JA, Lehmann N, et al. Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR). Eur Heart J. 2008;29:2782–91.PubMedCrossRefGoogle Scholar
  37. 37.
    • Möhlenkamp S, Lehmann N, Moebus S, et al. Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality. J Am Coll Cardiol. 57:1455–1464. This article describes the role of CAC and markers of systemic inflammation for risk assessment in general population.Google Scholar
  38. 38.
    • Möhlenkamp S, Lehmann N, Greenland P, et al. Coronary artery calcium score improves cardiovascular risk prediction in persons without indication for statin therapy. Atherosclerosis 215:229–236. This article describes the clinical significance of CAC in low-risk cohorts.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Amir A. Mahabadi
    • 1
  • Stefan Möhlenkamp
    • 1
  • Susanne Moebus
    • 2
  • Nico Dragano
    • 2
  • Hagen Kälsch
    • 1
  • Marcus Bauer
    • 1
  • Karl-Heinz Jöckel
    • 2
  • Raimund Erbel
    • 1
  • on behalf of the Heinz Nixdorf Investigator Group
    • 1
    • 2
  1. 1.Department of Cardiology, West-German Heart Center EssenUniversity of Duisburg-EssenEssenGermany
  2. 2.Institute of Medical InformaticsUniversity of Duisburg-EssenEssenGermany

Personalised recommendations